Cyproterone - Wikipedia
Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5 | BMC Cancer | Full Text
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity - Atherosclerosis
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Is hormonal treatment still an option in acne today? - Bettoli - 2015 - British Journal of Dermatology - Wiley Online Library
Hormonal treatment of acne vulgaris: an update | CCID
The chemical structures of steroidal (cyproterone acetate) and... | Download Scientific Diagram
Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial - The Journal of Sexual Medicine
Pharmacology of cyproterone acetate - Wikiwand
Androgen Physiology, Pharmacology, Use and Misuse - Endotext - NCBI Bookshelf
Molecules | Free Full-Text | Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions | HTML
Cyproterone acetate: Uses, Interactions, Mechanism of Action | DrugBank Online
Androgens - drdhriti
Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer | British Journal of Cancer
Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer | Future Oncology
Cyproterone Acetate - an overview | ScienceDirect Topics
Cyproterone acetate - Wikipedia
Cyproterone acetate, Androgen receptor antagonist (CAS 427-51-0) (ab142416)
Steroidal 5α-Reductase: A Therapeutic Target for Prostate Disorders | IntechOpen
JaypeeDigital | eBook Reader
Pharmacology of cyproterone acetate - Wikiwand
References in Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial - The
